StemiRNA Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
32
StemiRNA Therapeutics General Information
Description
Developer of mRNA technology-based physical products designed for the medical field. The company's technology utilizes a proprietary LPP nanotechnology-based delivery platform, AI-driven drug design, and mRNA synthesis capabilities, enabling healthcare providers to access stable vaccines and personalized oncology immunotherapies for infectious diseases and cancer.
Contact Information
Website
www.stemirna.comCorporate Office
- Room 402, Building 2
- Number 1295 Chuanqiao Road, Pudong New Area
- Shanghai, 200100
- China
Corporate Office
- Room 402, Building 2
- Number 1295 Chuanqiao Road, Pudong New Area
- Shanghai, 200100
- China
StemiRNA Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 25-May-2023 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 26-Sep-2021 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 28-May-2021 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 30-Mar-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series A1) | 21-Feb-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 01-Jul-2019 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 06-Jun-2018 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 06-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Sep-2017 | $3M | $3M | Completed | Generating Revenue | |
| 1. Secondary Transaction - Private | 09-Apr-2017 | Completed | Generating Revenue |
StemiRNA Therapeutics Comparisons
Industry
Financing
Details
StemiRNA Therapeutics Competitors (3)
One of StemiRNA Therapeutics’s 3 competitors is BioNTech, a Formerly VC-backed company based in Mainz, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioNTech | Formerly VC-backed | Mainz, Germany | ||||
| Arcturus Therapeutics Holdings | Formerly VC-backed | San Diego, CA | ||||
| Moderna | Formerly VC-backed | Cambridge, MA |
StemiRNA Therapeutics Patents
StemiRNA Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024131726-A1 | Broad-spectrum influenza mrna vaccine | Inactive | 19-Dec-2022 | ||
| WO-2024098360-A1 | Artificial nucleic acid molecule | Inactive | 11-Nov-2022 | ||
| WO-2024098361-A1 | Artificial nucleic acid molecule | Inactive | 11-Nov-2022 | ||
| WO-2024094211-A1 | Lipid composition | Inactive | 06-Nov-2022 | ||
| WO-2024032611-A1 | Lipid composition | Inactive | 09-Aug-2022 | A61K9/1272 |
StemiRNA Therapeutics Investors (32)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Spinnotec | Venture Capital | Minority | ||
| Oceanpine Capital | Growth/Expansion | Minority | ||
| Qianhai Great Wall Fund Management (Shenzhen) | Growth/Expansion | Minority | ||
| Silver Capital (China) | Venture Capital | Minority | ||
| Advantech Capital Partners | PE/Buyout | Minority |
StemiRNA Therapeutics FAQs
-
When was StemiRNA Therapeutics founded?
StemiRNA Therapeutics was founded in 2016.
-
Where is StemiRNA Therapeutics headquartered?
StemiRNA Therapeutics is headquartered in Shanghai, China.
-
What industry is StemiRNA Therapeutics in?
StemiRNA Therapeutics’s primary industry is Drug Discovery.
-
Is StemiRNA Therapeutics a private or public company?
StemiRNA Therapeutics is a Private company.
-
What is StemiRNA Therapeutics’s current revenue?
The current revenue for StemiRNA Therapeutics is .
-
How much funding has StemiRNA Therapeutics raised over time?
StemiRNA Therapeutics has raised $208M.
-
Who are StemiRNA Therapeutics’s investors?
Spinnotec, Oceanpine Capital, Qianhai Great Wall Fund Management (Shenzhen), Silver Capital (China), and Advantech Capital Partners are 5 of 32 investors who have invested in StemiRNA Therapeutics.
-
Who are StemiRNA Therapeutics’s competitors?
BioNTech, Arcturus Therapeutics Holdings, and Moderna are competitors of StemiRNA Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process